Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,847 | 154 | 99.8% |
| Education | $6.25 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $838.89 | 47 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $543.04 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $323.27 | 22 | $0 (2021) |
| Medtronic, Inc. | $239.42 | 2 | $0 (2021) |
| PFIZER INC. | $201.63 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $127.21 | 9 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $106.59 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $103.48 | 7 | $0 (2019) |
| Medtronic Vascular, Inc. | $83.12 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.52 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $247.08 | 10 | Gilead Sciences, Inc. ($55.77) |
| 2023 | $83.42 | 4 | Janssen Pharmaceuticals, Inc ($40.69) |
| 2022 | $198.66 | 11 | Janssen Pharmaceuticals, Inc ($77.02) |
| 2021 | $579.78 | 20 | Medtronic, Inc. ($239.42) |
| 2020 | $398.58 | 17 | Janssen Pharmaceuticals, Inc ($218.01) |
| 2019 | $436.73 | 31 | E.R. Squibb & Sons, L.L.C. ($209.42) |
| 2018 | $446.10 | 31 | Novartis Pharmaceuticals Corporation ($125.43) |
| 2017 | $462.53 | 31 | E.R. Squibb & Sons, L.L.C. ($118.17) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.79 | General |
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Cardiovascular | ||||||
| 08/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $38.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.98 | General |
| 04/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Cardiovascular | ||||||
| 02/09/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/25/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/31/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Cardiology | ||||||
| 01/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: DIABETES | ||||||
| 04/15/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: DIABETES | ||||||
| 02/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: DIABETES | ||||||
| 01/20/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 689 | 1,199 | $410,841 | $89,620 |
| 2022 | 8 | 728 | 1,398 | $487,124 | $108,885 |
| 2021 | 8 | 855 | 1,575 | $547,343 | $129,251 |
| 2020 | 7 | 871 | 1,580 | $511,247 | $125,159 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 234 | 700 | $184,978 | $42,883 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 116 | 120 | $88,182 | $15,624 | 17.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 121 | 123 | $48,037 | $10,770 | 22.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 98 | $37,118 | $8,956 | 24.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 107 | 112 | $29,774 | $6,942 | 23.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 46 | $22,752 | $4,446 | 19.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 240 | 544 | $196,708 | $44,695 | 22.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 155 | 516 | $130,266 | $29,094 | 22.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 100 | 101 | $70,941 | $15,398 | 21.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 159 | 163 | $60,731 | $13,540 | 22.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $10,844 | $2,387 | 22.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $6,664 | $1,375 | 20.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 23 | 23 | $5,897 | $1,293 | 21.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 20 | 20 | $5,073 | $1,102 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 266 | 645 | $225,369 | $54,091 | 24.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 167 | 496 | $120,688 | $28,759 | 23.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 123 | 128 | $87,558 | $19,682 | 22.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 200 | 207 | $74,157 | $17,640 | 23.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 30 | 30 | $18,690 | $4,170 | 22.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 44 | 44 | $10,709 | $2,490 | 23.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $6,510 | $1,523 | 23.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $3,662 | $895.49 | 24.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 263 | 517 | $178,722 | $44,006 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 234 | 677 | $161,846 | $39,716 | 24.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 208 | 215 | $76,369 | $18,663 | 24.4% |
About Dr. Jignesh Patel, MD
Dr. Jignesh Patel, MD is a Internal Medicine healthcare provider based in Altoona, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962639419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jignesh Patel, MD has received a total of $2,853 in payments from pharmaceutical and medical device companies, with $247.08 received in 2024. These payments were reported across 155 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,847).
As a Medicare-enrolled provider, Patel has provided services to 3,143 Medicare beneficiaries, totaling 5,752 services with total Medicare billing of $452,914. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Altoona, PA
- Active Since 06/11/2009
- Last Updated 10/19/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962639419
Products in Payments
- XARELTO (Drug) $838.89
- ELIQUIS (Drug) $725.12
- ENTRESTO (Drug) $323.27
- Resolute (Device) $239.42
- BRILINTA (Drug) $127.21
- LifeVest (Device) $106.59
- ZERBAXA (Drug) $103.48
- Telescope (Device) $83.12
- JARDIANCE (Drug) $60.70
- TEFLARO (Drug) $39.29
- Soliris (Drug) $23.83
- SAMSCA (Drug) $23.32
- AVYCAZ (Drug) $23.23
- OPSUMIT (Drug) $22.65
- Fetroja (Drug) $22.62
- VYNDAQEL (Drug) $19.55
- PRADAXA (Drug) $14.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Altoona
Dr. Mitul Patel, Md, MD
Internal Medicine — Payments: $110,465
Dr. Medhat Zaher, Md, MD
Internal Medicine — Payments: $7,312
Zane Gates, M.d, M.D
Internal Medicine — Payments: $5,749
James Gerardo, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $3,375
Khushboo Patel, M.d, M.D
Internal Medicine — Payments: $2,869
Anju Gupta, M.d, M.D
Internal Medicine — Payments: $1,805